DBV Technologies | Bienes

Assets Cambio Fecha
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Galectin Therapeutics USD 28.2M 6.04M 2023-12
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
United Therapeutics USD 7.17B 143.4M 2023-12



DBV Technologies Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.